Epidemiology of cervical cancer

Cancer Investigation

Volumn 18, Issue 6, 2000, Pages 584-590

  Mohar, Alejandro ^a,b   Frías Mendívil, Mauricio ^b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; VIRUS DNA;

CANCER INCIDENCE; CANCER MORTALITY; DISEASE ASSOCIATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0342646896     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009012198     Document Type: Review

References (59)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606, 1993.
2. Parkin DM, Muir CS, Whelan SL, et al, eds: Cancer Incidence in Five Continents, Vol. VII, IARC Scientific Publication 120, International Agency for Research on Cancer, 1997.
3. Alvarez-Gelvez JC, Pérez-Arias F: Provincial cancer registry, La Plata. In: Cancer Occurrence in Developing Countries, edited by DM Parkin, ARC Scientific Publications, 75, 1986, pp. 133-141.
4. Hakama M, Louhivuori K: A screening program for cervical cancer that work. Cancer Surv 7:403-416, 1988.
5. Ponten J, Adami HO, Bergstrom R, et al: Strategies for global control of cervical cancer. Int J Cancer 60:1-26, 1995.
6. Devesa SS, Blot WJ, Stone BJ, et al: Recent cancer trends in the United States. J Natl Cancer Inst 87:175-182, 1995.
7. Lazcano-Ponce EC, Alonso de Ruiz P, López-Carrillo L, et al: Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta Cytol 40:1-8, 1996.
8. Hill GB: Mortality from malignant neoplasms of the uterus since 1950. World Health Stat Rep 28:323-327, 1975.
9. Pisani P, Parkin DM, Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891-903, 1993.
10. Mohar A, Frías M, Suchil L, et al: Epidemiología descriptiva de cáncer en el Instituto Nacional de Cancerología de México. Salud Pub Mex 39:253-258, 1997.
11. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA Cancer J Clin 45:8-30, 1995.
12. Schairer C, Brinton LA, Devesa SS, et al: Racial differences in the risk of invasive squumous-cell cervical cancer. Cancer Causes Control 2:283-290, 1991.
13. Herrero R: Epidemiology of cervical cancer. Monogr Natl Cancer Inst 21:1-6, 1996.
14. Kjaer SK, Brinton LA: Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 15: 486-498, 1993.
15. Ursin G, Peters RK, Henderson BE, et al: Oral contraceptive use and adenocarcinoma of cervix. Lancet 344:1390-1394, 1994.
16. Zheng T, Holford TR, Ma Z, et al: The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomena. Int J Epidemiol 25:252-258, 1996.
17. Eluf-Nieto J, Booth M, Muñoz N: Human papillomavirus and invasive cancer in Brazil. Br J Cancer 69:114-119, 1994.
18. Anuario Estudístico de la Dirección General de Estadística e Informática. Mortalidad 1996. Secretaría de Salud, México, 1997.
19. Hernández-Avila M, Lazcano-Ponce EC, Berumen-Campos J, et al: Human papilloma virus 16-18 infection and cervical cancer in Mexico: a case-control study. Arch Med Res 28:265-271, 1997.
20. Torroella-Kouri M, Morsberger S, Carrillo A, et al: HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 70:115-120, 1998.
21. Tapia R, Kuri P, Macías MC, et al, eds: Registro Histopatológico de Neoplasias Malignas en México. Morbilidad y Mortalidad, Bienio 1993-1994, Tendencias 1985-1994, Secretaría de Salud, México, 1996.
22. Mohar A, Frías-Mendívil M, Suchil L, et al: Epidemiología del cáncer cérvico uterino en México. Ann Oncol (Esp) 7:222-227, 1998.
23. Gómez-González E, Mota A, Guadarrama L, et al: Radioterapia en carcinoma cérvico uterino. Experiencia y resultados en el Instituto Nacional de Cancerología. Ann Oncol (Esp) 7:261-266, 1998.
24. zur Hausen H, Rosi F: Pathogenesis of Cancer of the Cervix. Cold Spring Harbor Symposia on Quantitative Biology, Vol. LIX, New York, Cold Spring Harbor Laboratory Press, 1994, pp. 623-628.
25. Franco EL: The sexually transmitted disease model for cervical cancer: incoherent epidemiological findings and the role of misclassification of human papillomavirus infection. Epidemiology 2:98-106, 1991.
26. Cason J, Kaye J, Best JM: Non-sexual acquisition of human genital papillomaviruses. Papillomavirus Rep 1:1-7, 1995.
27. Bauer HM, Hildesheim A, Schiffman MH, et al: Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 20:274-278, 1993.
28. Ley C, Bauer HM, Reingold A, et al: Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83:997-1003, 1991.
29. Lorincz AT, Reid R, Jenson B, et al: Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337, 1992.
30. Schiffman MH, Bauer HM, Hoover RN, et al: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958-964, 1993.
31. Chichareon A, Herrera R, Muñoz N, et al: Report: risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90:50-57, 1998.
32. Lombard I, Vincent-Salomon A, Validire P, et al: Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 16:2613-2619, 1998.
33. Bosch FX, Muñoz N, de San José S, et al: Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52:750-758, 1992.
34. Howley PM: Role of the human papillomaviruses in human cancer. Cancer Res 51(18 Suppl):5019s-5022s, 1991.
35. Olsen AO, Gjoen K, Sauer T, et al: Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case control study. Int J Cancer 6:312-315, 1995.
36. Bosh FX, Muñoz N, de Sunjosé S, et al: Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prevent 70:415-422, 1993.
37. Mansur CP, Androphy AJ: Cellular transformation by papillomavirus oncoproteins. Biochem Biophys Acta 1155:323-345, 1993.
38. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
39. Koutsky L: Role of epidemiology in defining events that influence transmission and natural history of anogenital papillomavirus infections. J Natl Cancer Inst 83:96-97, 1991.
40. Bosch FX, Manos M, Muñoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796-802, 1995.
41. IARC: Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 64, Human Papillomavirus, Lyon, International Agency for Research on Cancer, 1995.
42. Lowy DR, Kirnhauer R, Chiller JT: Genital human papillomavirus infection. Proc Natl Acad Sci USA 91:2436-2440, 1994.
43. Schiffman MH: Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 84:394-398, 1992.
44. Cullen AP, Reid R, Campion M: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J Virol 65:605-612, 1991.
45. Schiffman MH, Brinton L, Devesa S, et al: Cervical cancer. In: Cancer Epidemiology and Prevention, 2nd ed. edited by D, Shottenfeld, JR Fraumeni Jr, New York, Oxford University Press, 1996, pp. 1090-1116.
46. Remminck AJ, Walboomers JM, Helmehosrts TJ, et al: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61:306-311, 1995.
47. Flannelly G, Anderson D, Kitchener HC: Management of woman with mild and moderate cervical dyskariosis. Br Med J 308:1399-1403, 1994.
48. Brinton LA. Reeves WC, Brenes MM, et al: Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 60:1-26, 1990.
49. Potischman N: Nutritional epidemiology of cervical neoplasia. J Nutr 123:424-429, 1993.
50. Hildescheim A, Schiffman MH, Gravitt PE, et al: Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235-240, 1994.
51. Palefsky J: Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. Monogr Natl Cancer Inst 23:15-20, 1998.
52. Apple RJ, Becjer TM, Wheeler CM, et al: Comparison of human leukocyte antigen DR-DQ disease association found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 87: 427-436, 1995.
53. de Sanjosé S. Muñoz N, Bosch FX, et al: Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 56:358-363, 1994.
54. Vonka V, Kanka J, Hirsch I: Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer 33:61-66, 1984.
55. WHO Collaborative Study of Neoplasia and Steroid Contraceptives: Invasive squamous cervical carcinoma and combined oral contraceptives: results from a multinational study. Int J Cancer 55:228-236, 1993.
56. Pater A, Bayatpour M, Pater MM: Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 162:1099-1103, 1990.
57. McCann MF, Irwin DE, Walton LA: Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and non-smokers. Cancer Epidemiol Biomarker Prevent 1:125-129, 1992.
58. Hildescheim A, Gravitt P, Schiffman MH, et al: Determinants of genital human papillomavirus infection in low income women in Washington D.C. Sex Transm Dis 20:279-285, 1993.
59. Lazcano-Ponce EC. Nájera-Aguilar P, Alonsode Ruiz P, et al: Programa de detección oportuna de cáncer de México I. Diagnóstico situacional. Rev Inst Nal Cancerol (Mex) 42:123-140, 1996.